In obese individuals, elevated leptin may contribute to low-grade inflammation, rendering them more susceptible to cardiovascular diseases; whereas in dilated cardiomyopathy, leptin is a biomarker for the progression of heart failure independent of immune responses (76). Here, LEP is linked to heart failure.